Company / Operating Cash Flow
BIOADAPTIVES, INC. Operating Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$516.0K
FY2025
5-year range
-$516.0K / -$158.7K
FY2021-FY2025
Trend
-106.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 7 years, ranging from -$516,025 in FY2025 to -$106,889 in FY2020.
Based on SEC 10-K filings.
-$516,025 in FY2025.
Declined from -$223,773 to -$516,025 over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 106.8% year-over-year.
- Peak operating cash flow was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -61.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$516.0K | -106.8% |
| FY2024 | -$249.5K | -11.5% |
| FY2023 | -$223.8K | +1.5% |
| FY2022 | -$227.3K | -43.2% |
| FY2021 | -$158.7K | -48.4% |
| FY2020 | -$106.9K | +36.4% |
| FY2019 | -$168.1K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026